8-K
Current Report
Niagen Bioscience, Inc. Filed Acc 0001628280-21-025140
Material agreement · New debt or obligation
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
From the SEC's structured data for this filing
Loading cdxc-20211211.htm…